Recent advances demonstrate artificial intelligence's role in augmenting routine medical imaging. A study utilizing AI identified thoracic aortic aneurysms during breast MRI scans, providing an opportunistic screening method. Additionally, South Korea's regulatory authorities approved Vuno Inc's ECG-based AI software for kidney dysfunction screening, indicating growing integration of AI tools for real-time diagnostics and risk assessment. These innovations highlight potential for improved clinical workflows, disease detection, and personalized medicine through machine learning in imaging.